WHO adopts antibodies created by Lankenau researchers as a standard to ensure quality control of polio vaccines worldwide
WYNNEWOOD, Pa., Dec. 9, 2022. Human antibodies cloned by scientists at the Lankenau Institute for Medical Research (LIMR), part of Main Line Health, have been adopted by the World Health Organization as a crucial part of its plan to permanently...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials
More News: Clinical Trials | International Medicine & Public Health | Pharmaceuticals | Polio | Polio Vaccine | Research | Vaccines | WHO